Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 27Phase 1/2 13Phase 3 3Phase 2/3 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Recurrence 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic Pancreatic Adenocarcinoma 1Malignant Solid Tumor 1Lymphoma, T-Cell 1Lymphoma 1

Interventions

Azacitidine 2pembrolizumab 1ioversol 1interferon gamma-1b 1fludarabine phosphate 1fluarix 1daratumumab 1Whole-Body Irradiation 1Transplantation 1Stem Cell Transplantation 1Photopheresis 1Pemetrexed 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Mesenchymal Stem Cell Transplantation 1Injections 1Influenza Vaccines 1Hyperbaric Oxygenation 1Fluzone High-Dose 1FluLaval 1FluBlok 1Decitabine 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Myelodysplastic Syndromes × Decitabine × Clear all
NCT04187703 2026-05-18

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
Myeloid

Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡